Complete paraplegia after nelarabine treatment in a T-cell acute lymphoblastic leukemia adult patient

被引：29
|
作者：
Papayannidis, Cristina [1 ]
Iacobucci, Ilaria [1 ]
Abbenante, Maria Chiara [1 ]
Curti, Antonio [1 ]
Paolini, Stefania [1 ]
Parisi, Sarah [1 ]
Baccarani, Michele [1 ]
Martinelli, Giovanni [1 ]
机构：
[1] Univ Bologna, Inst Hematol Oncol L&A Seragnoli, S Orsola Malpighi Hosp, I-40126 Bologna, Italy
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2010年 / 85卷 / 08期
关键词：
D O I：
10.1002/ajh.21719
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：608 / 608
页数：1
相关论文
共 50 条
  • [21] A Case of T-Cell Acute Lymphoblastic Leukemia after Treatment of Acute Promyelocytic Leukemia
    P. C. Bee
    G. G. Gan
    J. V. Sangkar
    A. Teh
    K. Y. Goh
    International Journal of Hematology, 2004, 79 : 358 - 360
  • [22] Coma associated with nelarabine in an elderly patient with T-cell acute lymphoblastic leukemia and severe chronic renal disease
    Nishijima, Tomohiro F.
    Shea, Thomas C.
    Wood, William A.
    Voorhees, Peter M.
    Jamieson, Katarzyna
    LEUKEMIA & LYMPHOMA, 2016, 57 (04) : 957 - 960
  • [23] Central nervous system neurotoxicity associated with nelarabine in T-cell acute lymphoblastic leukemia
    Pehlivan, Umur A.
    Gurkan, Emel
    Acar, Ibrahim H.
    Bicakci, Yunus K.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (01) : 246 - 251
  • [24] Safety of nelarabine in adults with relapsed or refractory T-cell acute lymphoblastic leukemia/lymphoma
    Candoni, Anna
    Lazzarotto, Davide
    Petruzzellis, Giuseppe
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (07) : 751 - 756
  • [25] Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemia
    Shimony, Shai
    Liu, Yiwen
    Valtis, Yannis K.
    Paolino, Jonathan D.
    Place, Andrew E.
    Brunner, Andrew M.
    Weeks, Lachelle D.
    Silverman, Lewis B.
    Vrooman, Lynda M.
    Neuberg, Donna S.
    Stone, Richard M.
    DeAngelo, Daniel J.
    Luskin, Marlise R.
    BLOOD ADVANCES, 2023, 7 (07) : 1092 - 1102
  • [26] Nelarabine Combination Therapy for Relapsed or Refractory T-Cell Acute Lymphoblastic Lymphoma/Leukemia
    Shimony, Shai
    Liu, Yiwen
    Valtis, Yannis K.
    Paolino, Jonathan D.
    Place, Andrew E.
    Brunner, Andrew M.
    Weeks, Lachelle D.
    Silverman, Lewis B.
    Vrooman, Lynda M.
    Neuberg, Donna S.
    Stone, Richard M.
    DeAngelo, Daniel J.
    Luskin, Marlise R.
    BLOOD, 2022, 140 : 8989 - 8990
  • [27] NELARABINE AS A RESCUE TREATMENT FOR FAILED INDUCTION OF LABOR COMPARED WITH PEDIATRIC PATIENTS WITH T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Molinos Quintana, A.
    Perez de Soto, C.
    Perez Lopez, O.
    Perez Simon, J. A.
    Perez Hurtado, J. M.
    HAEMATOLOGICA, 2017, 102 : 320 - 321
  • [28] Nelarabine and optimisation of therapy for T-cell acute lymphoblastic leukaemia
    Ghara, Niharendu
    Saha, Vaskar
    LANCET HAEMATOLOGY, 2023, 10 (06): : E391 - E393
  • [29] T-cell acute lymphoblastic leukemia occurring in a patient with acute promyelocytic leukemia
    Liso, V
    Specchia, G
    Pannunzio, A
    Mestice, A
    Palumbo, G
    Biondi, A
    HAEMATOLOGICA, 1998, 83 (05) : 471 - 473
  • [30] Nelarabine in T-cell acute lymphoblastic leukemia: intracellular metabolism and molecular mode-of-action
    Hormann, Femke M.
    Rudd, Sean G.
    LEUKEMIA, 2025, 39 (03) : 531 - 542
12345